Position in ZTS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$274,217
-$901,854 QoQ
Shares Held
3,816
-61.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#950
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PERSONAL CFO SOLUTIONS, LLC holds $2,203,089 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,316 | $1,094,866 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
17,738 | $284,340 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
3,816 | $274,217 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
21,926 | $219,260 | |
| 5 | VTRS |
Viatris Inc
|
11,151 | $177,077 | |
| 6 | HLN |
Haleon plc
|
16,434 | $153,329 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $274,217 | 3,816 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,176,071 | 9,949 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,279,211 | 10,167 | Shares | Defined | 2026-01-22 | |
| 2025-09-30 | $1,469,638 | 10,044 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $1,606,752 | 10,303 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,524,494 | 9,259 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $1,393,377 | 8,552 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,374,693 | 7,036 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,169,139 | 6,744 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,090,896 | 6,447 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $856,980 | 4,342 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $766,903 | 4,408 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $733,786 | 4,261 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $744,486 | 4,473 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $652,000 | 4,449 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $711,050 | 4,795 | Shares | Defined | 2022-11-01 | |
| 2022-06-30 | $837,963 | 4,875 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $967,089 | 5,128 | Shares | Defined | 2022-05-02 | |
| 2021-12-31 | $1,880,983 | 7,708 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,488,277 | 7,666 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $1,806,573 | 9,694 | Shares | Defined | 2021-07-22 | |
| 2021-03-31 | $1,701,413 | 10,804 | Shares | Defined | 2021-04-21 | |
| 2020-12-31 | $1,762,078 | 10,647 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,000 | 10,099 | Shares | Defined | 2020-11-02 | |
| 2020-06-30 | $1,373,140 | 10,020 | Shares | Defined | 2020-08-03 | |
| 2020-03-31 | $1,121,938 | 9,533 | Shares | Defined | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||